Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Bioatla Inc
BCABCurrent price
1.4 USD
+0.01 USD (+0.72%)
Last closed
1.37 USD
Company
www.bioatla.com
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
84 846 368 USD
Yield for 12 month
-85.82 %
Week
Month
Year
BCAB
BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ovarian cancer. It also develops BA3021, a CAB ADC for multiple solid tumor types, including NSCLC, melanoma, and head and neck cancer; and BA3071, which is a CAB anti-cytotoxic T-lymphocyte-associated antigen 4 antibody for renal cell carcinoma, NSCLC, small cell lung cancer, hepatocellular carcinoma, melanoma, bladder cancer, gastric cancer, and cervical cancer. BioAtla, Inc. was founded in 2007 and is based in San Diego, California. Address: 11085 Torreyana Road, San Diego, CA, United States, 92121
Analytics
WallStreet Target Price
12.25 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
+250 000 USD
Current Quarter
–
Last Quarter
–
Current Year
–
Last Year
+250 000 USD
Current Quarter
–
Last Quarter
–
Key Figures BCAB
1 year
3 years
5 years
10 years
EBITDA
-128 560 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-47.62 %
PEG Ratio
–
Return On Equity TTM
-104.56 %
Wall Street Target Price
12.25 USD
Revenue TTM
–
Book Value
1.98 USD
Revenue Per Share TTM
–
Dividend Share
–
Quarterly Revenue Growth YOY
31.6 %
Dividend Yield
–
Gross Profit TTM
-79 347 000 USD
Earnings Share
-2.65 USD
Diluted Eps TTM
-2.65 USD
Most Recent Quarter
III 2023
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics BCAB
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History BCAB
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation BCAB
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
134.3737
Price Sales TTM
989.2236
Enterprise Value EBITDA
0.4223
Price Book MRQ
0.8959
Financials BCAB
1 year
3 years
5 years
10 years
| Results | 2019 | Dynamics |
Technical indicators BCAB
For 52 weeks
1.24 USD
10.83 USD
50 Day MA
1.63 USD
Shares Short Prior Month
4 076 504
200 Day MA
2.65 USD
Short Ratio
9.22
Shares Short
4 123 925
Short Percent
9.36 %
Google
Apple
Facebook